Wednesday, June 01, 2022

#ExploringMining #Podcast 279 - News from (NYSE: $AG) (TSXV: $DSV.V) (TSX: $STGO.TO) (CSE: $CCR.C)

#ExploringMining #Podcast 279 - News from (NYSE: $AG) (TSXV: $DSV.V) (TSX: $STGO.TO) (CSE: $CCR.C)   

 


Vancouver, Kelowna, Delta, BC, June 1, 2022 Investorideas.com, a global investor news source covering mining and metals stocks releases today’s edition of Exploring Mining Podcast, featuring stock news from TSX, TSXV ,CSE, ASX, NASDAQ, NYSE  companies plus interviews with CEO's and leading experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2022/060122-Mining.mp3

 

Read this in full at https://www.investorideas.com/news/2022/exploring-mining/06011AG-DSV-STGO-CCR.asp

 

Listen to Exploring Mining podcast on iTunes Apple podcasts   

 

Listen to Exploring Mining on Spotify

 

First Majestic Silver Corp. (NYSE:AG) has reported positive drill results from its ongoing exploration program at the Jerritt Canyon Gold Mine in Elko County, Nevada, USA. According to the press release, the company has completed over 70,000 metres in exploration drill holes and plans to drill approximately 135,000 metres in 2022. Keith Neumeyer, President and CEO of First Majestic, said:

 

"Today's exploration results validate our thesis that Jerritt Canyon possesses tremendous mineral potential between the SSX and Smith mines as well as across the entire 30,821 hectare land packageWe have identified a high-grade underground mineralized pod near current mining activities, and we plan to advance the area toward ore production in the coming quarters. In addition, we have discovered numerous near surface gold mineralizations that have the potential to grow into large, new gold deposits for open pit mining.”

 

Discovery Silver Corp. (TSXV:DSV) has shared a project update, including news on the Pre-Feasibility Study, for its flagship Cordero project in Mexico’s Chihuahua State. Taj Singh, the company’s President & CEO, said:

 

We are very pleased with the excellent progress we have made on our PFS and to be working with the same industry-leading project team that completed our Preliminary Economic Assessment (PEA). Initial results from the PFS metallurgical testwork program highlight the exceptional metallurgical performance at Cordero with recoveries typically ranging from 90-95% for Ag, Pb and Zn from the tests completed so far. These recoveries have been achieved at a very coarse grind size and with lower reagent consumption than what was assumed in the 2021 PEA. All other aspects of the PFS are tracking well and we remain on schedule to deliver the Study in the fourth quarter of this year.”

 

Steppe Gold Ltd. (TSX:STGO) has shared an operations update for May 2022. Highlights include two gold pours in the month for a total of approximately 3,800 oz Au, as well as the setting up of “an exploration camp at the Uudam Khundii (UK) project located in the highly prospective Bayankhongor gold belt in Western Mongolia with first drilling programmes underway.” The company’s President and CEO Bataa Tumur-Ochir, commented:

 

"We are very pleased to report another strong month of production in May at the ATO Gold Mine. All activities at the site are operating well. Our design work for the Phase 2 Expansion is ongoing and the process of selection of contractors is underway. We are also very excited to commence exploration drilling at the highly prospective UK project."

 

Green River Gold Corp. (CSE:CCR) has posted an update on the progress of the 2022 exploration drilling program at its Quesnel Nickel/Talc/Magnesium project, in the Cariboo Mining District of British Columbia, Canada. Perry Little, President and CEO of Green River Gold Corp., said:

 

"We are in the process of expanding the known area of mineralized talc on the property. Finding nickel, chromium and titanium 600 meters from the area that we are currently drilling increases our confidence that the mineralized talc we are currently drilling is not just a localized phenomenon.”

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Research mining stocks at Investorideas.com with our mining stocks directory at Investorideas.com https://www.investorideas.com/Gold_Stocks/Stocks_List.asp 

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be a guest or sponsor this podcast

800-665-0411

 

 


Get more mining stock investor ideas- news, articles, podcasts and stock directories

 

Investor Ideas #Potcasts 632, #Cannabis News and #Stocks on the Move- Interview with CEO of Flora Growth Corp. (NASDAQ: $FLGC)

Investor Ideas #Potcasts 632, #Cannabis News and #Stocks on the Move- Interview with CEO of Flora Growth Corp. (NASDAQ: $FLGC)

 


Delta, Kelowna, BC, June 1, 2022 (Investorideas.com Newswire), investorideas.com,  a global news source covering leading sectors including marijuana and hemp stocks and its potcast site  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2022/060122-Cannabis-FLGC.mp3

 

Read this in full at https://www.investorideas.com/news/2022/cannabis-potcasts/06011Interview-Flora-Growth-Corp.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

In today’s podcast, Investorideas interviews Luis Merchan, CEO of Flora Growth Corp. (NASDAQ:FLGC), where we discussed the company’s last few months of business, the CBD market coming out of Colombia as well as the CBD industry over all and what is on the horizon for Flora Growth Corp. moving forward.

 

Speaking on the last few months of Flora Growth’s business development, specifically their acquisition and development of JustCBD,, Merchan commented, “It seems like every month is a meaningful month in terms of progress and execution of our strategy. Starting with the acquisition of JustCBD, which is a leading brand in the CBD space in the United States, which is the most sought after market in the entire world. We expect sales of CBD to triple over the next five years as adoption continues to rise and there are a number of categories that are leading the pace when it comes to growth and JustCBD plays in all of them.

 

Flora Growth Corp. recently announced that JustCBD will be launching its line of Novel Foods registered CBD products on Amazon.co.uk.

 

Amazon UK entered the now £700 million CBD market in October 2021 and has since expanded the initial pilot-only program to include vendors who have demonstrated their compliance with the UK CBD Novel Food regulations. Producers awarded with UK Novel Food authorization must prove the product is safe for consumption and labeled correctly.

 

"With health and wellness playing an increasingly important role in customers’ lives, we are excited to increase the selection of quality CBD products offered to Amazon customers in the UK," said Hussein Rakine, CEO of JustCBD. "The JustCBD team looks forward to working closely with Amazon to expand our product offering to other countries as our partnership and brand presence in the United Kingdom grows."

 

JustCBD’s product line is expected to launch on Amazon.co.uk in June of 2022 and will make available a portfolio of JustCBD’s best-selling gummies and tinctures.

 

"International growth is a key objective of our company’s strategy. The launch on Amazon UK allows Flora to reach a larger consumer base in search of quality CBD products," said Luis Merchan, CEO of Flora Growth. "We are excited to continue expanding our operations in Europe and to deliver top-quality cannabis-related products to customers aiming to improve their health and wellness."

 

The JustCBD acquisition was timed with changes in Colombia as Merchan mentioned, “Colombia has had some meaningful changes, starting with Resolution 227, which basically immediately allowed our strategy to come into play out of Colombia with the manufacturing, production and export of CBD infused products. Immediately after that resolution was completed we proceeded to complete our first export of products.”

 

Speaking on how Colombia will fit into the global cannabis industry, Mechan commented, “Our hypothesis early on, several years ago when we were founding the company was, that Colombia would become the Green BreadBasket of the World. The first growth pillar of Flora, is without a doubt, the Plant. We are going to have the opportunity over the next few months to have the opportunity to start exporting dry flower and exporting some of these finished products to a number of countries around the world while generating a significant of economic benefit to the Colombian population which has been frankly decimated over the last few decades wit the war on drugs. The single greatest advantage that you have with being in Colombia, is you are able to take advantage of all the knowhow, the agricultural knowhow, the fact that Colombia is on the equator, and grow a high quality product at one of the lowest production costs in the world. Now with the changes in the regulatory environment, Colombia will be at the vanguard of cannabis distribution and Flora will be leading the charge.”

 

Flora Growth Corp. also recently announced that the Company has formally begun the integration of its licensed and Control Union Medical Cannabis Standard GACP ("CUMCS-GACP") certified cannabis products and derivatives into its global roster of branded products. Beginning with CBD derivatives used in its award-winning skincare brand, Mind Naturals, the Company has begun the process of integrating significantly lower-cost cannabinoids, grown and extracted at Flora’s cultivation and extraction facility, Cosechemos, for products formulated at the Company’s GMP-licensed laboratory in Bogota, Colombia.

 

This event marks a milestone in Flora’s integration strategy, allowing Flora to further its global supply chain efficiencies and independence while bolstering its competitive advantage in white label and wholesale businesses.

 

"The key to unlocking the potential of the global cannabis market is supply chain mastery - this is our focus," Flora CEO Luis Merchan said. "Connecting our high-quality derivatives with our significant portfolio of revenue-producing global brands is a significant step in maximizing compounded value creation from seed to shelf."

 

Flora shows little sign of slowing down having also announced that it has entered into an agreement with leading cell biologist, Dr. Annabelle Manalo-Morgan, Ph.D., to acquire her brand Masaya, together with its patent-pending CBD formulations. Created by Dr. Annabelle and backed by her research, Masaya’s formulations of pure, potent CBD oil are 100% THC-free and have a long track record of positive testimonials collected over years of use. Flora intends to distribute the brand and its formulations worldwide.

 

Masaya will become an owned Flora brand sold in the US and will be the first offering from Flora Life Sciences. In addition, it is expected that the original patent-pending formulation, Masaya Pure, will be used in Flora’s current clinical trials with the University of Manchester in the UK. The formulation is also in the process of being registered with the Colombian regulatory agency, INVIMA, as one of the first distribution steps beyond the US.

 

Merchan went on to discuss some of the difficulties of importing/exporting CBD and cannabis products, how Flora has helped separate themselves from their local Colombian competition as well as what he expects for Flora moving forward.

 

To find out more information regarding Flora Growth Corp. visit their website here.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast. 

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

#AIEye #Podcast - GBT (OTC: $GTCH) CTO Discusses Hippocrates, qTerm, and #AI in #Healthcare #artificialintelligence



 


 

#AIEye #Podcast - GBT (OTC: $GTCH) CTO Discusses Hippocrates, qTerm, and #AI in #Healthcare #artificialintelligence

 

#Stocks discussed: (OTCPINK: $GTCH) (NYSE: $IBM) (NasdaqGS: $AAPL) (NasdaqGS: $MSFT)

 

Vancouver, Kelowna, Delta, BC – June 1, 2022  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye, featuring an exclusive interview with the CTO of technology company,  GBT Technologies Inc. (OTCPINK:GTCH).

 

Watch the video on YouTube:

https://www.youtube.com/watch?v=hHXQWQptYRY

 


Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/053122-AI-Eye-GBT.mp3

 

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/06011GTCH.asp

 

Hear the Ai Eye on Spotify  

 

As the adoption of artificial intelligence (AI) and its adjacent technologies in the healthcare space increases, so too does its use cases within the sector. In a recent interview with Investorideas.com, Danny Rittman, the CTO of GBT Technologies Inc. (OTC PINK:GTCH) highlighted the way AI is being leveraged in GBT’s own healthcare tech IP’s, and in the healthcare and medicine domain more broadly.

 

“We’ve seen AI in healthcare develop rapidly in the past decade or so,” Rittman said. “Major corporations, like IBM (NYSE:IBM), Apple (NasdaqGS:AAPL) and others stepped in and introduced apparatuses like wearables, as well as AI systems in other forms. IBM was one of the first major players with Watson, which was and is still a huge project, providing analytics in the cancer domain and others.”

 

GBT’s intelligent health advisory system, codenamed Hippocrates, leverages the company’s Avant! AI engine. Rittman explained Hippocrates and how it can be used as an assistant to physicians.

 

“We actually had the Hippocrates more than six months ago. It’s basically the core of Avant!, our AI engine, which we implemented here for the health domain,” he said. “Avant! can be adapted to any domain, but since the company has been moving into this area for the past few years, we decided to take the core of the Avant! and make it the Hippocrates system, which is going to be a health advisor. The Hippocrates system will have all the information taken from the CDC and the National Health Institute, so all the official accredited information, along with medical textbooks that we train the system with. With that, it will have its initial and vast database to be able to provide health tips and advice as a first line.”

 

“So, you can ask Hippocrates, and the system will initiate a dialog with the user … and try to diagnose as a first line, but not as a replacement for a physician,” Rittman said. “Each case is recorded, the system is trained, and next time it will know more. The system gains knowledge with time.”

 

A report published by Precedence Research, for instance, finds that the global market for AI in Healthcare is projected to grow from $11.06 billion USD in 2021 to over $187.95 billion by 2030, registering a compound annual growth rate (CAGR) of 37 percent from 2022-30. One of the factors cited in the report as a market driver is the use of wearables. Rittman explained the status of GBT’s own wearable medical device, the qTerm, which measures human vitals information (oxygen, heart rate and body temperature), as well as how it works.

 

“We’ve successfully completed the prototypes and we’re now building its mobile application that is more representative, and includes some analytics,” he said. “I estimate we’ll release it within the next month or two. After its launch, we will immediately start its integration with the Hippocrates system. That’s the plan for the qTerm, along with adding more features to it.”

 

“A user can sit at home, take their vitals, and at the doctor’s office they’ll be able to use the widget on our website to enter the qTerm’s ID and see the patient’s vitals,” he said. “We think this is great, because it allows telemedicine from anywhere around the world directly to your doctor’s office. This will also be supervised by the AI system.”

 

Perhaps one of the best known pieces of wearable tech is Apple’s Apple Watch. It was recently reported that researchers at the Mayo Clinic used an AI algorithm to interpret single-lead electrocardiogram (ECG) tracings from an Apple Watch and “effectively identified patients with a weak heart pump.” Itzhak Zachi Attia, the lead AI scientist in the Department of Cardiovascular Medicine at Mayo Clinic, explained:

 

"Approximately 420 patients had a watch ECG recorded within 30 days of a clinically ordered echocardiogram, or ultrasound of the heart, a standard test to measure pump strength. We took advantage of those data to see whether we could identify a weak heart pump with AI analysis of the watch ECG. While our data are early, the test had an area under the curve of 0.88, meaning it is as good as or slightly better than a medical treadmill test. AI analysis of the watch ECG is a powerful test to identify a weak heart pump."

 

Elsewhere in the space, BeeKeeperAI, described as “a pioneer in zero trust, confidential computing and privacy-preserving analytics for the training, validation, and deployment of artificial intelligence (AI) in healthcare,” recently announced that it had expanded its collaboration with Microsoft (NasdaqGS:MSFT) to “allow algorithm developers and healthcare data stewards to access through the Microsoft Azure Marketplace, thereby accelerating AI-Powered Innovation in Healthcare. Michael Blum, MD, Co-founder and CEO of BeeKeeperAI, said:

 

“Through our collaboration with Microsoft and our use of Microsoft Azure services, we have developed key insights that will help to prepare the healthcare AI marketplace for confidential computing and provide resources to help data stewards and algorithm developers to effectively work in this new environment. We chose Azure because of its privacy and security for data and algorithms as well as the infrastructure needed to compute at scale, in the cloud, across multiple locations.”

 

These instances are just a sample of all the exciting ways AI is being used in healthcare and medicine. Rittman particularly highlighted the AI’s ability in managing data as an asset in its applicability in the space.

 

“I think one of its major advantages is to encapsulate a vast amount of datasets, handling big data, and by doing that providing assistance and suggestions or pointing out potential possibilities to the medical team,” Rittman said.

 

But regardless of AI’s increasing ubiquity in healthcare, Rittman insists on the primacy of actual doctors.

 

“We do not believe AI systems will replace the actual medical team or professionals,” he said. “The physician is the ultimate authority.”

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

About GBT Technologies Inc.

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: GTCH is a paid featured AI stock on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp 

Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories